CIK 0001130166 · Non-accelerated filer<br>Smaller reporting company
Bio Green Med Solution, Inc.
Sign in to watch- Tickers
- BGMS BGMSP
- Exchange
- Nasdaq, OTC
- Industry
- Wholesale-Durable Goods, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911766850
- Phone
- 908-517-7330
- Business address
- 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC
Securities
- BGMS Common Stock Nasdaq
- BGMSP Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +42,438 | 42,438 | ||
| 2023-06-30 | McBarron Paul See Remarks | Grant or award · Stock Option (right to buy) | +70,200 | 70,200 | ||
| 2023-06-30 | Kirschbaum Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +70,200 | 70,200 | ||
| 2023-06-30 | Walker Karin L Director | Grant or award | +21,219 | 40,602 | ||
| 2023-06-30 | Walker Karin L Director | Grant or award · Stock Option (right to buy) | +42,438 | 42,438 | ||
| 2023-06-30 | Ferguson Kenneth M. Director | Grant or award | +21,219 | 44,952 | ||
| 2023-06-30 | Ferguson Kenneth M. Director | Grant or award · Stock Option (right to buy) | +42,438 | 42,438 | ||
| 2023-06-30 | HENNEY CHRISTOPHER S Director | Grant or award | +21,219 | 39,415 | ||
| 2023-06-30 | HENNEY CHRISTOPHER S Director | Grant or award · Stock Option (right to buy) | +42,438 | 42,438 | ||
| 2023-06-30 | SCHWARTZ BRIAN Director | Grant or award | +21,219 | 40,602 | ||
| 2023-06-30 | SCHWARTZ BRIAN Director | Grant or award · Stock Option (right to buy) | +42,438 | 42,438 | ||
| 2023-01-31 | McBarron Paul See Remarks | Grant or award | +31,200 | 31,492 | ||
| 2023-01-31 | Rombotis Spiro George President and CEO | Grant or award | +57,600 | 62,588 | ||
| 2023-01-31 | Kirschbaum Mark Chief Medical Officer | Grant or award | +31,200 | 31,200 | ||
| 2022-06-14 | Ferguson Kenneth M. Director | Grant or award | +23,733 | 23,733 | ||
| 2022-06-14 | Ferguson Kenneth M. Director | Grant or award · Stock Option (right to buy) | +47,467 | 47,467 | ||
| 2022-06-14 | Ferguson Kenneth M. Director | Grant or award | +27,733 | 27,733 | ||
| 2022-06-14 | Ferguson Kenneth M. Director | Grant or award · Stock Option (right to buy) | +47,467 | 47,467 | ||
| 2022-06-14 | Walker Karin L Director | Grant or award | +15,822 | 19,383 | ||
| 2022-06-14 | Walker Karin L Director | Grant or award · Stock Option (right to buy) | +31,645 | 31,645 |
Page 4 of 24 · 475 trades